The Risk Factors for Ischemic Heart Disease in Tibetan Highlanders

Japanese Heart Journal

Volumn 30, Issue 1, 1989, Pages 27-34

  Fujimoto, Naoki ^a   Matsubayashi, Kozo ^b   Miyahara, Tadao ^c   Murai, Atsushi ^c   Matsuda, Minoru ^d   Shio, Hideo ^d   Suzuki, Hajime ^d   Kameyama, Masakuni ^d   Saito, Atsuo ^e   Shuping, Li ^f  

^a Medical Center for Adult Diseases ^*  (Japan)

^b Kochi University School of Medicine   (India)

^c Tokyo Medical University   (Japan)

^d KYOTO UNIVERSITY HOSPITAL   (Japan)

^e Shin Kawabata Hospital ^*  (Japan)

^f China Mountaineering Association ^*  (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; FATTY ACID; LINOLEIC ACID;

ADULT; ATHEROSCLEROSIS; ATTITUDE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOCRIT; HUMAN; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC HYPERTENSION;

ALTITUDE; BLOOD PRESSURE; CHINA; CHOLESTEROL; CORONARY DISEASE; FATTY ACIDS; FEMALE; HUMAN; LIPIDS; MALE; MIDDLE AGE; REFERENCE VALUES; RISK FACTORS; TRIGLYCERIDES;

EID: 0024557195     PISSN: 00214868     EISSN: 1348673X     Source Type: Journal    
DOI: 10.1536/ihj.30.27     Document Type: Article

References (17)

1. Carlson LA, Böttiger LE, Åhfeldt PE: Risk factors for myocardial infarction in the Stockholm prospective study. Acta Med Scand 206: 351, 1979
2. Tohgi H, Yamanouchi H, Murakami M, Kameyama M: Importance of the hematocrit as a risk factor in cercbral infarction. Stroke 9: 369, 1978
3. Ruiz L, Figueroa M, Horna C, Peñaloza D: Prevalencia de la hipertension arterial y cardiopatia isquemica en las grandes alturas. Archos Inst Cardiol 39: 474, 1969
4. Ramos DA, Krüger H, Muro M. Arias-Stella J: Pathologia del hombre nativo de las grandes alturas. Investigacion de las causas de muerte en 300 autopsias. Boletín de la Oficina Sanitaria Panamericano 62: 496, 1967
5. Hultgren HN: Reduction of systemic arterial blood pressure at high altitude. Adv Cardiol 2: 49, 1970
6. Avogaro P, Bittolo Bon G, Cazzolato G, Rorai E: Relationship between apolipoproteins and chemical components of lipoproteins in survivors of myocardial infarction. Atherosclerosis 37: 69, 1930
7. Miettinen TA, Naukkarinen V, Huttunen JK, Mattila S, Kumlin T: Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J 285: 993, 1982
8. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR: Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2: 117, 1978
9. Goto Y, Akanuma Y, Harano Y, Hata Y, Itakura H, Kajiyama G, Kawade M, Koga S, Kuzuya F, Maruhama Y, Matsuzawa Y, Murai A, Murase T, Naito C, Nakai T, Noma A, Saitoh Y, Sasaki J, Takeuchi N, Tamachi H, Uzawa H, Yamamoto A, Yamazaki S, Yasugi T, Yukawa S: Determination by the SRID method of normal values of serum apolipoproteins (A-I, A-II, B, C-II, C-III, and E) in normolipidemic healthy Japanese subjects. J Clin Biochem Nutr 1: 73, 1986
10. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chera 226: 497, 1957
11. Hurtado A, Merino C, Delgado E: Influence of anoxemia on hemopoietic activity. Arch Intern Med 75: 284, 1945
12. Weinsier RL, Fuchs RJ, Kay TD, Triebwasser JH, Lancaster MC; Body fat; Its relationship to coronary heart disease, blood pressure, lipids and other risk factors measured in a large male population. Am J Med 61: 815, 1976
13. Murai A, Tanaka T, Miyahara T, Kameyama M: Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke 12: 167, 1981
14. Norm KR, Berg T, Drevon CA: Cholesterol transport and lecithin: cholesterol acyltransferase. in Metabolic Risk Factors in Ischemic Cardiovascular Disease, ed by Carlson LA, Pernow B, Raven Press, New York, p 35, 1982
15. Sanders TAB, Roshanai F: The influence of different types of ω3 polyun-saturated fatty acids on blood lipids and platelet function in healthy volunteers. Clin Sci 64: 91, 1983
16. Saynor R, Verel D, Gillott T: The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis 50: 3, 1984
17. Terano T, Hirai A, Hamazaki T, Kobayashi S, Fujita T, Tamura Y, Kumagai A: Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects. Atherosclerosis 46: 321, 1983